AYAN THERAPEUTICS INC.,

Ayan Therapeutics, a spin-out from Altus Enterprises, is dedicated to delivering clinically differentiated and affordable therapeutics to the global market. Within the Altus Enterprise ecosystem, we possess modular capabilities encompassing cell culture, protein production, advanced analytics, robotics-guided automated screening, and a cutting-edge data science platform. Our approach is guided by seasoned experts with a proven track record in establishing successful companies and forging strategic partnerships, including extensive experience in infrastructure and capacity development on an international scale.

​

Ayan is establishing collaborations with multinational corporations, governmental agencies, and other industry stakeholders to drive innovation in drug development, regulatory sciences, non-clinical and clinical studies, as well as product commercialization